Maxim Group Reiterates $8.00 Price Target for BioLife Solutions (BLFS)

Maxim Group set a $8.00 target price on BioLife Solutions (NASDAQ:BLFS) in a report released on Thursday, January 4th. The firm currently has a buy rating on the medical equipment provider’s stock.

BioLife Solutions (NASDAQ BLFS) traded down $0.10 on Thursday, hitting $5.71. 31,800 shares of the stock traded hands, compared to its average volume of 60,700. BioLife Solutions has a 12-month low of $1.69 and a 12-month high of $7.53. The firm has a market capitalization of $80.06, a P/E ratio of -13.60 and a beta of 0.27.

BioLife Solutions (NASDAQ:BLFS) last posted its quarterly earnings data on Thursday, November 9th. The medical equipment provider reported ($0.03) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.06) by $0.03. BioLife Solutions had a negative net margin of 10.76% and a negative return on equity of 24.29%. The firm had revenue of $2.96 million for the quarter, compared to the consensus estimate of $2.60 million. sell-side analysts forecast that BioLife Solutions will post -0.21 earnings per share for the current fiscal year.

A number of large investors have recently modified their holdings of BLFS. Granite Investment Partners LLC acquired a new position in BioLife Solutions in the 3rd quarter valued at about $1,205,000. EAM Investors LLC purchased a new position in BioLife Solutions during the third quarter worth about $555,000. Finally, Essex Investment Management Co. LLC purchased a new position in BioLife Solutions during the third quarter worth about $484,000. Institutional investors own 9.15% of the company’s stock.

WARNING: This report was first reported by BBNS and is the property of of BBNS. If you are viewing this report on another website, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this report can be accessed at https://baseballnewssource.com/markets/biolife-solutions-blfs-pt-set-at-8-00-by-maxim-group/1818438.html.

BioLife Solutions Company Profile

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Houston Astros Add Starter to Rotation
Houston Astros Add Starter to Rotation
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Justin Morneau Former Star With Twins and AL MVP Retires
Justin Morneau Former Star With Twins and AL MVP Retires
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets


Leave a Reply

 
© 2006-2018 BBNS.